09996.HK
Peijia Medical Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 5.07
−1.36%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4B | 712.9M | 615.5M | 441.1M | 250.8M |
| Cost of Revenue | 463.7M | 226.8M | 181.9M | 115.8M | 74.6M |
| Gross Profit | 982.1M | 486.1M | 433.6M | 325.4M | 176.2M |
| Operating Expenses | |||||
| R&D Expense | 481.8M | 266.7M | 233.1M | 293.4M | 373.1M |
| SG&A Expense | 883.3M | 446.8M | 479.4M | 466.6M | 365.1M |
| General & Admin Expense | 268.7M | 126.0M | 151.1M | 141.6M | 123.4M |
| Selling & Marketing Expense | 614.5M | 320.8M | 328.3M | 325.0M | 241.6M |
| Other Expenses | (60.6M) | (28.8M) | (39.6M) | (3.9M) | (119.4M) |
| Total Operating Expenses | 1.3B | 684.7M | 673.0M | 756.1M | 618.7M |
| Cost and Expenses | 1.8B | 911.5M | 854.8M | 871.9M | 693.4M |
| Operating Income (EBIT) | (344.3M) | (198.7M) | (239.3M) | (430.8M) | (442.5M) |
| Non-Operating | |||||
| Interest Income | 10.3M | 7.8M | 22.5M | 39.4M | 46.6M |
| Interest Expense | 15.3M | 11.7M | 4.7M | 178.0K | 2.3M |
| Net Interest Income | (10.5M) | (3.9M) | 17.7M | 39.3M | 44.3M |
| Other Non-Op Income/Expense | (10.7M) | (3.9M) | 17.7M | 39.3M | 44.3M |
| Non-Operating Income (excl Interest) | (14.5M) | (2.5M) | (9.3M) | (39.4M) | (119.4M) |
| EBT (Pre-Tax Income) | (355.0M) | (202.6M) | (221.6M) | (391.5M) | (398.2M) |
| Income Tax Expense | 19.4M | 5.6M | 6.9M | 1.1M | 9.6M |
| Bottom Line | |||||
| Net Income | (366.1M) | (203.3M) | (226.6M) | (392.5M) | (407.8M) |
| Earnings from Cont. Ops | (374.4M) | (208.2M) | (228.5M) | (392.6M) | (407.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (366.1M) | (203.3M) | (226.6M) | (392.5M) | (407.8M) |
| Per Share | |||||
| Basic EPS | (HK$0.55) | (HK$0.31) | (HK$0.34) | (HK$0.58) | (HK$0.61) |
| Diluted EPS | (HK$0.55) | (HK$0.31) | (HK$0.34) | (HK$0.58) | (HK$0.61) |
| Revenue Per Share | HK$2.16 | HK$1.07 | HK$0.92 | HK$0.65 | HK$0.37 |
| Shares | |||||
| Basic Shares Outstanding | 670.3M | 665.2M | 669.5M | 679.3M | 673.2M |
| Diluted Shares Outstanding | 670.3M | 665.2M | 669.5M | 679.3M | 673.2M |
| Profitability Metrics | |||||
| EBITDA | (197.2M) | (133.9M) | (176.6M) | (348.5M) | (359.9M) |
| D&A | 110.6M | 62.3M | 53.4M | 42.8M | 36.0M |
| EBIT | (307.4M) | (196.1M) | (229.7M) | (391.3M) | (395.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026